Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe 18 September 2023
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy 04 August 2023
CERENOVUS Announces Sustainability Commitment and Showcases New Product and Data Innovations at the Society of NeuroInterventional Surgery 20th Annual Meeting 27 July 2023
Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias 24 July 2023
Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe 19 July 2023
ASCO Abstract finds most HCPs are willing to engage in sustainability initiatives, but encounter frequent barriers to participation 26 May 2023
Biosense Webster Presents New Data from Pulsed Field Ablation Investigational Studies at Heart Rhythm 2023 19 May 2023
Biosense Webster Showcases Award-Winning Real-World Evidence Demonstrating Value of Catheter Ablation in Driving Improved Patient Outcomes in AFib at Heart Rhythm 2023 19 May 2023
Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI 18 May 2023
